TRIM7 antisense RNA 1 (TRIM7-AS1)

TRIM7 antisense RNA 1 (TRIM7-AS1) is a long noncoding RNA transcribed from the TRIM7 gene locus. Long noncoding RNAs (lncRNAs) are a type of RNA molecule greater than 200 nucleotides that do not encode proteins but may regulate gene expression through diverse mechanisms. As of now, there is limited scientific literature specifically characterizing TRIM7-AS1 in terms of biological function, therapeutic potential, or disease association. Most available information focuses on the protein-coding gene TRIM7, which encodes an E3 ubiquitin ligase implicated in immune signaling and cancer biology, while TRIM7-AS1 itself does not encode a protein and is not established as a standalone therapeutic target in pharmacology or clinical research. Notes: - TRIM7, not TRIM7-AS1, is the protein with well-documented roles in ubiquitin-mediated signaling, immunity, cancer, and other biological processes. - If you intended the ubiquitin ligase protein, the correct canonical name would be "Tripartite motif-containing protein 7 (TRIM7)". - There is no evidence that TRIM7-AS1 is a therapeutic target (e.g., enzyme, receptor, transporter, etc.) in the conventional sense. Summary of issues: - TRIM7-AS1 is a lncRNA, not a typical molecular target for drugs. - Most research and drug discovery relevant to “TRIM7” refer to the protein-coding gene, not the antisense RNA. - The entry "TRIM7 antisense RNA 1" is not a canonical therapeutic target and is considered incorrect for target-based drug discovery frameworks.

Other names

lncRNA TRIM7-AS1TRIM7-AS1 lncRNA